Table 3.

Health resurce utilization.

Laboratory monitoring (monthly frequency of testing)
	N+I [source]	D+T [source]
Renal	2.09†	1
Hepatic	2.09†	1†
Complete blood count	0†	1†
Thyroid	2.09†	0†
Electrolyte	0†	1†
Other HRUs	N+I [source]	D+T [source]
PICC lines per regimen	1*	N/A
Infusions/month	2.1	N/A
MD visits/month	2.1**	0***
Infusion time	1.0 Hr; nivolumab [16] 1.5 Hr; ipilimumab [17]	N/A
Wait time between infusions	30 min†	N/A
Time lost for travel to infusion clinic	1.0 h [20]	N/A
Time lost for travel to pharmacy and wait time for filling prescription	N/A	0.35 h [21,23]

^†Assumption.

^*Assumed one PICC line per patient for the full course of therapy.

^**Assumed one MD visit for each infusion.

^***Assumed one MD visit assumed for D+T for the initial prescription.